Final answer:
Pulmonary surfactants are the most likely drugs to help a newborn with Respiratory Distress Syndrome (RDS) when administered as an aerosol spray.
Step-by-step explanation:
The most likely drugs to help a victim of Respiratory Distress Syndrome (RDS) of the newborn when administered as an aerosol spray are pulmonary surfactants.
Pulmonary surfactants, composed of a mixture of lecithin and sphingomyelin lipids, are released into the lungs of newborn babies to reduce surface tension and facilitate inflation of the alveoli.
Pulmonary surfactant therapy has significantly reduced deaths due to RDS in infants.
Other therapies for RDS may include corticosteroids, supplemental oxygen, and assisted ventilation, but aerosolized pulmonary surfactants are the primary treatment.